Olivia Ashman

Views & Analysis

Pfizer’s Dr Olivia Ashman joined me for episode 16 of the pharmaphorum podcast, which focuses on the UK cancer landscape.

News

The MHRA has published its position paper clarifying how microbiome-based medicines can be made available for patients in the UK.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.